BIODEXA PHARMACEUTICALS PLC

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 59564R872 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Armistice Capital, LLC 13G/A Amendment 2	10.0%	26,166	13G/A Amendment 2	8/14/2026 Event 6/30/2026
Armistice Capital, LLC	10.0%	26,166
Steven Boyd	10.0%	26,166
Armistice Capital, LLC 13G/A Amendment 1	10.0%	187,975	13G/A Amendment 1	5/15/2026 Event 3/31/2026
Armistice Capital, LLC	10.0%	187,975
Steven Boyd	10.0%	187,975

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q2	7	16.6 k	$48.1 k	$0
2026 Q1	1	151	$93.00	$0